Ascent Solar Technologies, Inc. (NASDAQ: ASTI ),
a developer and manufacturer of state-of-the-art, flexible thin-film
photovoltaic modules integrated into the company’s EnerPlex™ series of
consumer products, announced today the receipt of the second tranche of
funds from the Stock Purchase Agreement (SPA) previously announced on
July 31, 2014.
By Gregor Stuart Hunter, Kosaku Narioka and Kwanwoo Jun
Exchanges in Asia are nervously eyeing a new trading link between Hong Kong and Shanghai, and mulling how to stay competitive on worries it will soak up funds from global money managers.
Operating income for the six month period ended June 30, 2014 increased to $1.4 million from $0.9 million for the comparable period of 2013
Life and health insurance premiums increased 3.7% in the comparable six month period
Property and casualty insurance premiums increased 28.0% in the comparable six month period
Book value per share at June 30, 2014 of $4.82 increased 7.8% from book value per share of $4.47 at December 31, 2013
By Laura He, MarketWatch
HONG KONG (MarketWatch) -- In the first case of its kind in China, search-engine leader Baidu is facing a lawsuit after a clinic claiming it could make gay men become heterosexual appeared atop its search results.
Berry Plastics Group, Inc. (NYSE: BERY), is proud to announce that its
Flexible Intermediate Bulk Containers (FIBC) group recently received two
significant awards from one of its valued customers: Eastman
Chemical Company .
DANBURY, CT--(Marketwired - August 11, 2014) - Biodel Inc. (NASDAQ: BIOD) today reported financial results for the third fiscal quarter ended June 30, 2014.
DANBURY, CT--(Marketwired - August 11, 2014) - Biodel Inc. (NASDAQ: BIOD) announced positive preliminary results from Study 3-152, a Phase 2a clinical trial comparing Biodel's proprietary, concentrated insulin formulation BIOD-531 to Humalog ®
Mix 75/25 and Humulin ® R U-500 in patients with type 2 diabetes with moderate insulin resistance who use between 50 and 200 units of insulin per day.
Sign-up for Biodel's Concentrated Insulin BIOD-531 Demonstrates Superior Glucose Control Following Standardized Meals Compared to Marketed Insulins in a Phase 2 Clinical Trial in Patients With Type 2 Diabetes investment picks
Corporation (NASDAQ:BIRT), The BIRT Company™ and leader in
personalized analytics and insights, today announced BIRT
PowerDocs™ is available for the Salesforce1 Mobile App, empowering
companies to run their business from their phone.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.